March 2017 in “Fundamental & Clinical Pharmacology” The model and estimator can predict drug exposure in kidney transplant patients well.
28 citations
,
October 2010 in “Targeted Oncology” Trastuzumab may cause tufted hair folliculitis as a side effect.
32 citations
,
March 2018 in “Neoplasia” Nephronectin is linked to worse breast cancer outcomes and helps cancer spread.
January 2015 in “Dermatología Venezolana” The document's conclusion cannot be summarized because the content is not available for analysis.
September 2024 in “International Journal For Multidisciplinary Research” Tridax procumbens shows potential for various health benefits but needs more scientific research.
4 citations
,
November 2015 in “Research Journal of Medicinal Plant” Tridax procumbens extracts can harm cell division and increase cell death in onion roots.
August 2023 in “Zenodo (CERN European Organization for Nuclear Research)” 2 citations
,
November 2024 in “In Silico Pharmacology” August 2023 in “Zenodo (CERN European Organization for Nuclear Research)” May 2011 in “Psychiatric News” Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.
June 2022 in “Zenodo (CERN European Organization for Nuclear Research)” November 2024 in “Actas Dermo-Sifiliográficas” N-acetylcysteine and memantine are recommended as safe and effective treatments for trichotillomania.
July 2014 in “Journal of the Portuguese Society of Dermatology and Venereology” Trichoscopy is useful for diagnosing and monitoring hair and scalp conditions.
June 2023 in “Zenodo (CERN European Organization for Nuclear Research)” February 2006 in “Inpharma Weekly”
1 citations
,
October 2024 in “Journal of King Saud University - Science” Tridax procumbens extracts may help treat cancer due to their strong anticancer and antioxidant properties.
The research created new azasteroids and pseudoazulenyl nitrones, which could be useful in medicine.
September 2021 in “Zenodo (CERN European Organization for Nuclear Research)” November 2025 in “Skin Appendage Disorders” Androgenetic alopecia doesn't increase the risk of heart-related health issues.
September 2025 in “Journal of the American Academy of Dermatology” Low-dose oral minoxidil does not significantly affect blood pressure in patients with hair loss and hypertension.
July 2025 in “Journal of Investigative Dermatology” Spironolactone can safely lower blood pressure in patients on other blood pressure medications, but may slightly increase the risk of low blood pressure.
July 2025 in “Journal of Investigative Dermatology” Low-dose oral minoxidil is safe for the heart in the short term for hair loss patients.
July 2024 in “Journal of Investigative Dermatology” Patients with cutaneous lupus erythematosus have a higher risk of skin cancer and other cancers.
July 2024 in “Journal of Investigative Dermatology” Treating gastrointestinal issues can reduce rosacea flares, and treating rosacea can lower gastrointestinal problems.
March 2023 in “The Journal of Urology” Nocturia cases increased, but medication use declined, suggesting under-treatment.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” Tridax procumbens is a promising herb for developing safe, affordable plant-based medicines.
1 citations
,
February 2018 in “Australasian journal of dermatology” Advanced imaging techniques are crucial for accurately diagnosing Monilethrix, a rare hair disorder.
Recognizing bamboo hair helps diagnose Netherton’s syndrome.
January 2025 in “Natural Product Research” Nyctanthes arbor-tristis has potential health benefits and needs more research for safe medicinal use.
19 citations
,
July 1997 in “British Journal of Dermatology” LHTric-1 is a specific antibody useful for studying hair and nail formation.